Femmes & VIH pays Sud - Médecins du Monde

Les femmes à l’épreuve du VIH dans les pays du Sudup to nine years from seroconversion. Italian Seroconversion Study. BMJ 1994 ; 309 :1537-42.34. Prins M, Robertson JR, Brettle RP, et al. Do gender differences in CD4 cell countsmatter ? AIDS 1999 ; 13 : 2361-4.35. Jarrin I, Geskus R, Bhaskaran K, et al. Gender differences in HIV progression to AIDSand death in industrialized countries : slower disease progression following HIV seroconversionin women. Am J Epidemiol 2008 ;168 : 532-40.36. Prins M, Meyer L, Hessol N. Sex and the course of HIV infection in the Pre-HAARTand HAART era : A review of the literature. AIDS 2005 ; 19 : 357-70.37. Ochieng-Ooko V, Ochieng D, Sidle JE, et al. Influence of gender on loss to follow-upin a large HIV treatment programme in western Kenya. Bull World Health Organ 2010 ;88 : 681-8.38. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adultsaccessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 2008 ;22 : 1897-908.39. Saada M, Le Chenadec J, Berrebi A, et al. Pregnancy and progression to AIDS :results of the French prospective cohorts. Anrs SEROGEST and SEROCO StudyGroups. AIDS 2000 ; 14 : 2355-60.40. van Benthem BH, Vernazza P, Coutinho RA, Prins M, The European Study on theNatural History of HIV Infection in women. The impact of pregnancy and menopauseon CD4 lymphocyte counts in HIV-infected women. AIDS 2002 ; 16 : 919-24.41. Fourquet F, Le Chenadec J, Mayaux MJ, Meyer L. Pregnancies in HIV-infectedwomen living in France. AIDS 2001 ; 15 : 2193-6.42. Myer L, Carter RJ, Katyal M, et al. Impact of Antiretroviral Therapy on Incidence ofPregnancy among HIV-Infected Women in Sub-Saharan Africa : A Cohort Study.PLoS Med 2010 ; 7 : e1000229.43. Curtis KM, Nanda K, N Kapp. Safety of hormonal and intrauterine methods of contraceptionfor women with HIV/AIDS : a systematic review. AIDS 2009 ; 23 (suppl 1) :S55-S67.44. Polis CB, Wawer MJ, Kiwanuka N, et al. Effect of hormonal contraceptive use on HIVprogression in female seroconverters in Rakai, Uganda. AIDS 2010 ; 24 : 1937-44.45. Harlow SD, Schuman P, Cohen M, et al. Effect of HIV infection on menstrual cyclelength. J Acquir Immune Defic Syndr 2000 ; 24 : 68-75.46. Clark RA, Mulligan K, Stamenovic E, et al. Frequency of anovulation and early menopauseamong women enrolled in selected adult AIDS clinical trials group studies. JInfect Dis 2001 ; 184 : 1325-7.47. Ellerbrock TV, Chiasson MA, Bush TJ, et al. Incidence of cervical squamous intraepitheliallesions in HIV-infected women. JAMA 2000 ; 283 : 1031-7.48. Heard I, Tassie JM, Kazatchkine MD, Orth G. Highly active antiretroviral therapyenhances regression of cervical intraepithelial neoplasia in HIV-seropositive women.AIDS 2002 ; 16 : 1799-802.49. Massad LS, Seaberg EC, Watts DH, et al. Low incidence of invasive cervical canceramong HIV-infected US women in a prevention program. AIDS 2004 ; 18 : 109-13.50. Agboghoroma CO. Gynaecological and Reproductive Health Issues in HIV-PositiveWomen. West Afr J Med 2010 ; 29 : 135-42.51. OMS, Onusida, Unicef. Towards Universal Access. Scaling up priority HIV/AIDS interventionsin the health sector. Progress report 2010, 150 p.14